(Q35172075)

6 August 2017

1 reference

title

Chemokines in autoimmunity: from pathology to therapeutics (English)

1 reference

6 August 2017

Steven L Kunkel

1

1 reference

6 August 2017

Nuria Godessart

series ordinal

2

1 reference

6 August 2017

publication date

1 December 2002

1 reference

6 August 2017

1 reference

6 August 2017

volume

1

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

313-320

1 reference

The biology of chemokines and their receptors

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Chemokines: a new classification system and their role in immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Chemokines: agents for the immunotherapy of cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Chemokines in pathology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Chemokine responses in schistosomal antigen-elicited granuloma formation.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Lymphocyte traffic control by chemokines

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Chemokines in autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Chemokine receptors: multifaceted therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

New therapeutics that modulate chemokine networks

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

CCR1-specific non-peptide antagonist: efficacy in a rabbit allograft rejection model

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

CCR3-blocking antibody inhibits allergen-induced eosinophil recruitment in human skin xenografts from allergic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Virokines: novel immunomodulatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

The molecular basis of lymphoid architecture and B cell responses: implications for immunodeficiency and immunopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

"Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Embryonic expression and function of the chemokine SDF-1 and its receptor, CXCR4.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

1 reference

https://api.crossref.org/works/10.1016%2FS1568-9972%2802%2900085-X

7 January 2021

10.1016/S1568-9972(02)00085-X

Identifiers

DOI

1 reference

6 August 2017

1 reference